On Feb. 1, Novartis Pharmaceuticals Canada Inc. announced that the Nova Scotia government is funding Pluvicto injections for ...

Researchers have identified two microRNA that may predict which individuals with cancer are at ... More men with limited life expectancy and certain localized prostate cancers have received ...

For men with high-risk prostate cancer and a five-year life expectancy, treatment rose from 17.3% to 46.5%. The researchers concluded that “overtreatment of men with limited LE [life expectancy ...

The city laid out a series of proposals to reduce cancer deaths by 20 percent, and deaths from heart- and diabetes-related ...

Because this kind of cancer ... cancer life expectancy. Higher stages mean that the cancer has spread further through the body and is more difficult to treat. This, in turn, will mean that the patient ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

For mesothelioma cancer patients, the life expectancy is roughly 4-18 months after diagnosis, depending on if the patient pursues treatment. Patients diagnosed early have a general life expectancy of ...

Neoadjuvant Therapy for Men with High Risk Disease Prior to Prostatectomy - Mary-Ellen Taplin ...

Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...

An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose treatment has stopped working, according to scientists. Experts ...